ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

June 12, 1992

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

HEW Money Bills Mark Up Set May 26

May 20, 1977

Gene Expression Data Posted On Web For Research Use.

March 17, 2000

In Brief: ACS Awards Professorship To Bernstein; HCFA Clears Dana-Farber For Medicare

August 11, 1995